Heyu Biological Technology Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HYBT research report →
Price Chart
About the company
Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on the research, development, and production of healthcare equipment. A key area of its present work involves developing the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical device intended for cancer treatment. This innovative equipment is designed to induce cold nuclear fusion via cosmic ray muons within a contained environment to combat the disease.
- CEO
- Ban Siong Ang
- IPO
- 1999
- HQ
- Xiamen, CN
Get TickerSpark's AI analysis on HYBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $361.36M
- P/E
- 175.00
- PEG
- -0.34
- P/S
- 31.89
- P/B
- 4.29
- EV/EBITDA
- 268.14
- Div Yield
- 0.00%
- Gross Margin
- 17.12%
- Op Margin
- 9.97%
- Net Margin
- 8.85%
- ROE
- 2.41%
- ROIC
- 1.88%
Latest fiscal year · YoY change
- Revenue
- $2.87M+7.1%
- Gross Profit
- $181.63K+161.9%
- Op Income
- $-377,401
- Net Income
- $-472,000-24.5%
- EPS
- $-0.00-12.5%
- OCF Growth
- -1077.7%
- FCF Growth
- +71.5%
- 52W High
- $3.40
- 52W Low
- $0.00
- 50D MA
- $0.46
- 200D MA
- $1.10
- Beta
- -17.89
- RSI (14)
- 41
- Avg Volume
- 498
No earnings-call transcripts are available for HYBT yet.
- Free Float
- 4.4%
- Shares Outstanding
- 1.03B
- Float Shares
- 44.93M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 28, 23 | Ang Ban Siong | sell | 28,328,194 |
| Sep 4, 23 | Gao Xingjia | other | 0 |
| Sep 4, 23 | Li Wei | other | 0 |
| Sep 1, 23 | Lin Zengqiang | other | 0 |
| Sep 1, 23 | Lin Zhenzhu | other | 0 |
| May 17, 23 | TAN HUNG SENG | buy | 20,000,000 |
| May 17, 23 | Ang Ban Siong | sell | 68,645,429 |
| Mar 20, 19 | Ang Ban Siong | sell | 109,006,861 |
| Apr 18, 18 | Master Daniel C | sell | 10,210,517 |
| Jun 20, 17 | Master Daniel C | buy | 100,000,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HYBT coverage
Recent articles, reports, and earnings notes.
No research on HYBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HYBT report →